Anne Grønborg Vedel

Anne Grønborg Vedel

Auto-generated profile, based on publicly available information

Anne Grønborg Vedel

Department of Cardiothoracic Anaesthesiology, Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2018 in Circulation
Verified
Journal Article
Closed access
AVAnne G. Vedel
Anne G. Vedel
FHFrederik Holmgaard
Frederik Holmgaard
LRLars S. Rasmussen
Lars S. Rasmussen
ALAnnika Langkilde
Annika Langkilde
OPOlaf Bjarne Paulson
Olaf Bjarne Paulson
JNJens C. Nilsson
Jens C. Nilsson
Background: Cerebral injury is an important complication after cardiac surgery with the use of cardiopulmonary bypass. The rate of overt stroke after cardiac surgery is 1% to 2%, whereas silent strokes, detected by diffusion-weighted magnetic resonance imaging, are found in up to 50% of patients. It is unclear whether a higher versus a lower blood pressure during cardiopulmonary bypass reduces cerebral infarction in these patients. Methods: In a patient- and assessor-blinded randomized trial, we allocated patients to a higher (70–80 mm Hg) or lower (40–50 mm Hg) target for mean arterial pressure by the titration of norepinephrine during cardiopulmonary bypass. Pump flow was fixed at 2.4 L·min −1 ·m −2 . The primary outcome was the total volume of new ischemic cerebral lesions (summed in millimeters cubed), expressed as the difference between diffusion-weighted imaging conducted preoperatively and again postoperatively between days 3 and 6. Secondary outcomes included diffusion-weighted imaging–evaluated total number of new ischemic lesions. Results: Among the 197 enrolled patients, mean (SD) age was 65.0 (10.7) years in the low-target group (n=99) and 69.4 (8.9) years in the high-target group (n=98). Procedural risk scores were comparable between groups. Overall, diffusion-weighted imaging revealed new cerebral lesions in 52.8% of patients in the low-target group versus 55.7% in the high-target group ( P =0.76). The primary outcome of volume of new cerebral lesions was comparable between groups, 25 mm 3 (interquartile range, 0–118 mm 3 ; range, 0–25 261 mm 3 ) in the low-target group versus 29 mm 3 (interquartile range, 0–143 mm 3 ; range, 0–22 116 mm 3 ) in the high-target group (median difference estimate, 0; 95% confidence interval, −25 to 0.028; P =0.99), as was the secondary outcome of number of new lesions (1 [interquartile range, 0–2; range, 0–24] versus 1 [interquartile range, 0–2; range, 0–29] respectively; median difference estimate, 0; 95% confidence interval, 0–0; P =0.71). No significant difference was observed in frequency of severe adverse events. Conclusions: Among patients undergoing on-pump cardiac surgery, targeting a higher versus a lower mean arterial pressure during cardiopulmonary bypass did not seem to affect the volume or number of new cerebral infarcts. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT02185885.

17 May 2016 in Trials
Verified
Journal Article
Open access
PDF file
AVAnne G. Vedel
Anne G. Vedel
FHFrederik Holmgaard
Frederik Holmgaard
LRLars Simon Rasmussen
Lars Simon Rasmussen
OPOlaf Bjarne Paulson
Olaf Bjarne Paulson
CTCarsten Thomsen
Carsten Thomsen
JNJens C. Nilsson
Jens C. Nilsson
Debilitating brain injury occurs in 1.6–5 % of patients undergoing cardiac surgery with cardiopulmonary bypass. Diffusion-weighted magnetic resonance imaging studies have reported stroke-like lesions in up to 51 % of patients after cardiac surgery. The majority of the lesions seem to be caused by emboli, but inadequate blood flow caused by other mechanisms may increase ischaemia in the penumbra or cause watershed infarcts. During cardiopulmonary bypass, blood pressure can be below the lower limit of cerebral autoregulation. Although much debated, the constant blood flow provided by the cardiopulmonary bypass system is still considered by many as appropriate to avoid cerebral ischaemia despite the low blood pressure. The Perfusion Pressure Cerebral Infarct trial is a single-centre superiority trial with a blinded outcome assessment. The trial is randomising 210 patients with coronary vessel and/or valve disease and who are undergoing cardiac surgery with the use of cardiopulmonary bypass. Patients are stratified by age and surgical procedure and are randomised 1:1 to either an increased mean arterial pressure (70–80 mmHg) or ‘usual practice’ (40–50 mmHg) during cardiopulmonary bypass. The cardiopulmonary bypass pump flow is fixed and set at 2.4 L/minute/m2 body surface area plus 10–20 % in both groups. The primary outcome measure is the volume of the new ischaemic cerebral lesions (in mL), expressed as the difference between a baseline, diffusion-weighted, magnetic resonance imaging scan and an equal scan conducted 3–6 days postoperatively. Secondary endpoints are the total number of new ischaemic cerebral lesions, postoperative cognitive dysfunction at discharge and 3 months postoperatively, diffuse cerebral injury evaluated by magnetic resonance spectroscopy and selected biochemical markers of cerebral injury. The sample size will enable us to detect a 50 % reduction in the primary outcome measure in the intervention compared to the control group at a significance level of 0.05 and with a power of 0.80. This is the first clinical randomised study to evaluate whether the mean arterial pressure level during cardiopulmonary bypass influences the development of brain injuries that are detected by diffusion-weighted magnetic resonance imaging. ClinicalTrials.gov, NCT02185885 . Registered on 7 July 2014.


22 November 2020 in Interactive CardioVascular and Thoracic Surgery
Verified
Journal Article
Open access
PDF file
SWSebastian Wiberg
Sebastian Wiberg
FHFrederik Holmgaard
Frederik Holmgaard
KBKaj Blennow
Kaj Blennow
JNJens C Nilsson
Jens C Nilsson
JKJesper Kjaergaard
Jesper Kjaergaard
AVAnne Grønborg Vedel
Anne Grønborg Vedel
Cardiac surgery is associated with risk of cerebral injury and mean arterial pressure (MAP) during cardiopulmonary bypass (CPB) is suggested to be associated with cerebral injury. The ‘Perfusion Pressure Cerebral Infarcts’ (PPCI) trial randomized patients undergoing coronary artery bypass grafting (CABG) and/or aortic valve replacement to a MAP of 40–50 or 70–80 mmHg during CPB and found no difference in clinical or imaging outcomes between the groups. We here present PPCI trial predefined secondary end points, consisting of biomarkers of brain injury. Blood was collected from PPCI trial patients at baseline, 24 and 48 h after induction of anaesthesia and at discharge from the surgical ward. Blood was analysed for neuron-specific enolase, tau, neurofilament light and the glial marker glial fibrillary acidic protein. Linear mixed models were used to analyse differences in biomarker value changes from baseline between the 2 MAP allocation groups. A total of 193 (98%) patients were included. We found no differences in biomarker levels over time from baseline to discharge between the 2 MAP allocation groups (PNSE = 0.14, PTau = 0.46, PNFL = 0.21, PGFAP = 0.13) and the result did not change after adjustment for age, sex and type of surgery. We found no significant differences in levels of biomarkers of neurological injury in patients undergoing elective or subacute CABG and/or aortic valve replacement randomized to either a target MAP of 40–50 mmHg or a target MAP of 70–80 mmHg during CBP.

19 March 2019 in Acta Anaesthesiologica Scandinavica
Verified
Journal Article
Closed access
PDF file
AVAnne G. Vedel
Anne G. Vedel
FHFrederik Holmgaard
Frederik Holmgaard
VSVolkert Siersma
Volkert Siersma
ALAnnika Langkilde
Annika Langkilde
OPOlaf Bjarne Paulson
Olaf Bjarne Paulson
LRLars S. Rasmussen
Lars S. Rasmussen

1 August 2021 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
SRSebastian Roed Rasmussen
Sebastian Roed Rasmussen
RNRikke Vibeke Nielsen
Rikke Vibeke Nielsen
FEFrank Eriksson
Frank Eriksson
MDMaria Dons
Maria Dons
AVAnne Grønborg Vedel
Anne Grønborg Vedel
HRHanne Berg Ravn
Hanne Berg Ravn